After Lightning-Paced Tier-1 Sellout, ClinTex’s CTi Token Lists on KuCoin Today

Bitcoin Press Release: ClinTex is all set to fulfil its promise of reducing cost and time wastage in the medical trials industry, with its CTi token available for public trading on KuCoin on Wednesday.

 

30th November 2020, London, United Kingdom: Using the combination of blockchain, artificial intelligence and smart contracts, ClinTex is an innovative medical trial platform that will usher in an era of data sharing, analytics and management in pharmaceutical development that will revolutionize the current industry. The aim: Eliminate issues that cause time and resources to be wasted and remove duplication of efforts.

 

Sharing is Caring

The pharmaceuticals industry is lucrative – an innovative medicine that can tackle a disease is worth billions in sales. However, the industry is littered with high barriers to entry and unfathomable lead times for products. Compounding these problems are the tough trial stages before drugs are approved for use. To offset this huge cost, the pharma industry simply passes on the cost to the public, with the sick paying huge amounts of money for their health. And in ClinTex’s view, this is unacceptable.

 

ClinTex is leveraging blockchain technology to herald a new age in medical trial data sharing that is secure, efficient and open. Their Clinical Trials Intelligence (CTi) platform utilizes data analytics combined with blockchain technology to address the major inefficiencies in clinical trials. Through this, the estimated $350 billion spent yearly on new medication development can be significantly reduced.

 

The CTi Platform will also enable better collaboration across the pharmaceutical industry. Currently, there are almost 3,000 studies ongoing that are evaluating Covid-19 treatments and vaccines, but most are working in isolation. Using blockchain technology, CTi will finally provide a way for Big Pharma, small Biotech, academia and  independent researchers to collaborate and share key data, allowing for faster clinical trials and less clinical trial failures.. This will support ClinTex’s vision of facilitating the delivery of new medicines Faster, Safer and Cheaper.

 

CTi Listing

Powering the ClinTex’s mission of serving humanity is its CTi token. The firm originally had an IEO in the plans, but the immense interest by participants meant ClinTex was ready to go to market with CTi much quicker. Purchased at an incredible pace, the first round completely sold out and the second round also saw unprecedented demand. ClinTex decided not to run additional, unnecessary rounds of the sale.

 

CTi has just been listed on KuCoin today, Monday 30th November, 2020 and publicly tradable in 2 days on Wednesday 2nd December, 2020. KuCoin stands amongst the top ten crypto exchanges and its high volume of trading means the token will be in the reach of hundreds of thousands of investors and individuals who share the ClinTex dream. With over 30,000 new clinical trials registered every year, and over 250,000 clinical trials ongoing at any one time, the market potential for CTi is huge. This market opportunity, coupled with ClinTex’s innovative platform, is likely to drive  significant demand for the token in the short term, with longer term sustainable token growth being driven by the roll-out of the platform in 2021. 

 

Open, Yet Secure

ClinTex offers a seamless experience of sharing medical data, but respects intellectual property at the same time. A recent report by The Guardian revealed that state sponsored hackers are constantly attempting to hack into the servers of pharma companies engaged in COVID-19 vaccine development. This is the very reason ClinTex uses blockchain. Smart contracts assure the information is released to the only right party, leading to a trustless environment.

 

Expert Opinion

Combined, the ClinTex team has over 50 years of experience in the pharma industry, with vast connections in the clinical trial sector. ClinTex is also all set to roll out its working platform in 2021. With the platform launched next year, the true power of medical trials and blockchain will be unleashed, bringing pharmacists, doctors, researchers and others under one roof, working in cohesion to make medications easier to develop and cost effective for the world. One world, one mankind, a global health benefit.

 

Join the medical revolution and trade CTi today on KuCoin!

 

Connect with ClinTex on Telegram: https://t.me/ClinTexCTi 

Join ClinTex on Twitter: https://twitter.com/ClinTexCTi 

Check up what ClinTex is up to on Medium: https://medium.com/@clintexcti 

 

About KuCoin

KuCoin is a global cryptocurrency exchange for numerous digital assets and cryptocurrencies. Launched in September 2017, KuCoin has grown into one of the most popular crypto exchanges and already has over 5 million registered users across 207 countries and regions around the world. One out of every four crypto holders in the world is with KuCoin.

 

Media Contact Details 

Contact Name: Sean Flanagan

Contact Email: info@clintex.io

 

ClinTex is the source of this content. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections.

 

About Bitcoin PR Buzz: Bitcoin PR Buzz has been proudly serving the crypto press release distribution needs of blockchain start-ups for over 8 years. Get your Bitcoin Press Release Distribution today.

 

The post After Lightning-Paced Tier-1 Sellout, ClinTex’s CTi Token Lists on KuCoin Today appeared first on Bitcoin PR Buzz.

Bitcoin PR Buzz – Massive Exposure For Bitcoin Services, Projects, and Merchants

Source: BPRB Feed

ClinTex’s Ongoing CTi Presale Gives Unparalleled Access to the $350bn Medical Trials Market

Bitcoin Press Release: ClinTex announce details of their CTi Token Presale, which will give participants access to the $350bn/year Clinical trials market with a 50% price discount until 25th September 2020.

 

17th August 2020, London, United Kingdom – With the current global pandemic sweeping the globe, the fiscal impact can be seen everywhere, and in industries once considered safe havens, impacts expected to last a decade are commonplace. From the tech moguls of Silicon valley, to the high-tech production centres of Europe, It is clear that the world is crying out for innovation in a time where opportunities are few and far between.

 

To this end, London-based company ClinTex says it has the answer to a disempowered financial ecosystem. It looks perfectly poised to provide a solution not only to medical patients worldwide, but the healthcare industry as a whole and of course, to provide a potentially amazing return to its stakeholders through its CTi token pre-sale, which is currently ongoing. 

 

Pharmaceutical Industry Inefficiencies 

The value proposition for ClinTex lies in one simple observed fact – For an industry which is considered cutting edge, the Pharmaceutical industry is fraught with inefficiency. In such a notable time for health globally, these inefficiencies are having widespread consequences:

 

  • Large Time Delays – A promising medicine can take up to 15 years to get to patients, with untold amounts of heartache and emotional trauma for families and individuals alike. The CTi platform will help issues to be detected and prevented generating millions in savings.

 

  • High Testing Cost – It now costs over $2,500,000,000 to get a drug to market, with every day in clinical trials costing up to $8,000,000 in revenue erosion for each day a new medicine is delayed – And that cost gets passed onto the patient. CTi will vastly reduce costs, helping deliver medicines not just faster, but cheaper to those who need it.

 

  • Poor Data Quality – With the Clinical Data Visualisation App in CTi, fundamental and systemic errors in data can rapidly be detected and addressed, leading to greater insights and far better data application. Developments like this lead to greater industry progression long-term.

 

  • Little-To-No Collaboration – Currently, there exists almost no collaboration between industry players. This problem has been been magnified with the covid-19 pandemic. The opportunities for efficiency by extracting  the intelligence and insights inherent in clinical data across the globe are many – This is perhaps one of the largest benefits – As the ecosystem grows in value, more partners sign up, and the value increases.

 

COVID-19 & CTi – Returns to Rival DeFi?
With the current pandemic raging on, and 142 COVID-19 vaccines currently awaiting trials, there has never been a better time for CTi’s implementation in the industry.  We are already seeing haphazard attempts at research collaboration in the hunt for a COVID-19 vaccine and treatments. And with these spends potentially reaching into the trillions, CTi could represent the next generation of innovative profits to follow DeFi in re-igniting the crypto wave not seen since the ICO boom of 2017. 

 

The CTi token pre-sale runs until 25th September 2020, and CTi can be purchased for a 50% discounted price of 0.05$ by visiting this link. $1m USD in CTi is available for purchase, which is equivalent to 10% of the total CTi supply. Leftover tokens will be burned, and the main sale commences in October 2020 where tokens will be available for $0.10.

 

ClinTex is doing what all companies strive to do in times of hardship – To innovate. And with a market valued at $350,000,000,000 per year, the possibilities are endless. Now is the time. Be a part of this exciting project and enjoy discounts on one of the industry’s most promising projects this year by visiting the CTi token presale link now.

 

ClinTex Website: https://www.clintex.io/

 

ClinTex Telegram: https://t.me/ClinTexCTi

 

ClinTex Twitter: https://twitter.com/ClinTexCTi

 

ClinTex Medium: https://medium.com/@clintexcti

 

Media Contact Details 

Contact Name: Sean Flanagan

Contact Email: info@clintex.io

 

ClinTex is the source of this content. This press release is for informational purposes only. The information does not constitute investment advice or an offer to invest. The ClinTex token sale is closed to US participants and participants of all countries in which ICO/IEOs are illegal. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. Token sales are only suitable for individuals with a high risk tolerance. Only participate in a token event with what you can afford to lose.

 

About Bitcoin PR Buzz: Bitcoin PR Buzz has been proudly serving the crypto press release distribution needs of blockchain start-ups for over 8 years. Get your Bitcoin Press Release Distribution today.

 

The post ClinTex’s Ongoing CTi Presale Gives Unparalleled Access to the $350bn Medical Trials Market appeared first on Bitcoin PR Buzz.

Bitcoin PR Buzz – Massive Exposure For Bitcoin Services, Projects, and Merchants

Source: BPRB Feed